dpi 201-106 has been researched along with ouabain in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhm, M; Erdmann, E; La Rosée, K; Mittmann, C; Schwinger, RH | 1 |
| Herzig, S; Lilienthal, E; Mohr, K | 1 |
| Berdeaux, A; Gérard, JL; Giudicelli, JF; Gosgnach, M | 1 |
| Scholtysik, G | 1 |
| Gerber, W; Salzmann, R; Scholtysik, G | 1 |
| Berdeaux, A; Gerard, JL; Giudicelli, JF | 1 |
| Kaumann, AJ; Richards, DE; Russell, DA | 1 |
| Scholtysik, G; Williams, FM | 1 |
8 other study(ies) available for dpi 201-106 and ouabain
| Article | Year |
|---|---|
Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Topics: Adult; Azetidines; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Membrane; Dose-Response Relationship, Drug; Female; Heart; Humans; In Vitro Techniques; Isoproterenol; Kinetics; Male; Middle Aged; Molecular Structure; Myocardial Contraction; Myocardium; Ouabain; Piperazines; Sodium Channels | 1991 |
The positive inotropic drugs DPI 201-106, BDF 9148, and veratridine increase ouabain toxicity and [3H]ouabain binding in guinea pig heart.
Topics: Animals; Cardiotonic Agents; Digitoxin; Drug Synergism; Female; Guinea Pigs; Heart; Male; Myocardial Contraction; Myocardium; Ouabain; Piperazines; Veratridine | 1991 |
Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Topics: Acetylcholine; Animals; Blood Flow Velocity; Cardiotonic Agents; Dobutamine; Dogs; Female; Hemodynamics; Injections, Intra-Arterial; Injections, Intravenous; Male; Milrinone; Nitroglycerin; Norepinephrine; Ouabain; Piperazines; Pyridones; Vasoconstriction; Vasodilation; Vasomotor System | 1991 |
Potentiating paired stimulation of cardiac muscle in vitro as positive inotropic reference standard.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Cardiotonic Agents; Electric Stimulation; Heart; In Vitro Techniques; Male; Myocardial Contraction; Ouabain; Piperazines; Pyridones; Rabbits; Ventricular Function | 1986 |
Interaction of DPI 201-106 with cardiac glycosides.
Topics: Anesthesia; Animals; Cardiac Glycosides; Cats; Dogs; Drug Interactions; Electrocardiography; In Vitro Techniques; Male; Myocardial Contraction; Ouabain; Papillary Muscles; Piperazines; Rabbits; Time Factors | 1989 |
Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Topics: Animals; Autonomic Nervous System; Cardiotonic Agents; Dobutamine; Dogs; Drug Interactions; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Piperazines; Pyridones | 1989 |
Inhibition of the sodium pump by cardioactive DPI 201-106.
Topics: Adenosine Triphosphatases; Animals; Biological Transport; Cats; In Vitro Techniques; Ouabain; Piperazines; Radioisotopes; Rubidium; Sodium | 1987 |
Antiarrhythmic effects of DPI 201-106.
Topics: Aconitine; Action Potentials; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Cats; Coronary Vessels; Female; Male; Ouabain; Piperazines; Rats; Rats, Inbred Strains | 1986 |